{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:52:03Z","timestamp":1795060323306,"version":"4.10.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Slow-wave sleep has been proposed to facilitate the removal of proteins, implicated in neurodegeneration, from the brain. While mechanistic evidence from animal models is accumulating, direct human data on how slow-wave sleep shapes cerebrospinal fluid (CSF) proteostasis remain limited, constraining our understanding of physiological resilience to neurodegenerative disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twelve healthy adults (aged 20\u201340 years) underwent CSF sampling following three controlled sleep conditions in a randomized crossover design; (1) one night of sleep followed by afternoon CSF sampling, (2) one night of sleep followed by morning CSF sampling, and (3) one night of total sleep deprivation followed by morning CSF sampling. Sleep and wakefulness were verified using polysomnography and actigraphy, with &gt;\u20094-week washout periods between conditions. Measured CSF biomarkers included Alzheimer\u2019s disease-related proteins: beta-amyloid isoforms (A\u03b238, A\u03b240, and A\u03b242), total tau, tau phosphorylated at amino acid 181 (p-tau), glial fibrillary acidic protein (GFAP), and neurofilament light chain, as well as orexin, albumin (also measured in serum), and osmolality. Differences between conditions were assessed using Friedman tests with Dunn\u2019s post hoc correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CSF levels of A\u03b2 and tau tended to be consistently lower after sleep compared with both afternoon sampling and post-sleep deprivation. Concurrently, CSF albumin levels increased after sleep, while neurofilament light and GFAP remained unchanged. Orexin levels rose markedly during sleep deprivation but showed no circadian variation and did not track with biomarker levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings support a model in which slow-wave sleep selectively reduces CSF concentrations of A\u03b2 and tau, potentially through enhanced solute mobility and receptor-mediated clearance. Unchanged levels of NfL and GFAP argue against bulk clearance. Orexin may primarily function to oppose sleep pressure rather than directly regulate proteostasis. These hypotheses merit direct testing to inform strategies for delaying pathological protein accumulation in neurodegenerative disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00698-x","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T12:04:00Z","timestamp":1755605040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sleep reduces CSF concentrations of beta-amyloid and tau: a randomized crossover study in healthy adults"],"prefix":"10.1186","volume":"22","author":[{"given":"Tim","family":"Lyckenvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Wasling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hanse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"6","key":"698_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.neuron.2025.02.004","volume":"113","author":"S Parhizkar","year":"2025","unstructured":"Parhizkar S, Holtzman DM. The night\u2019s watch: exploring how sleep protects against neurodegeneration. Neuron. 2025;113(6):817\u201337.","journal-title":"Neuron"},{"issue":"6","key":"698_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz F, et al. Processing and synaptic function. Neuron. 2003;37(6):925\u201337.","journal-title":"Neuron"},{"issue":"6","key":"698_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48(6):913\u201322.","journal-title":"Neuron"},{"issue":"4","key":"698_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, et al. Physiological release of endogenous Tau is stimulated by neuronal activity. EMBO Rep. 2013;14(4):389\u201394.","journal-title":"EMBO Rep"},{"issue":"3","key":"698_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, et al. Neuronal activity regulates extracellular Tau in vivo. J Exp Med. 2014;211(3):387\u201393.","journal-title":"J Exp Med"},{"issue":"8","key":"698_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, et al. Neuronal activity enhances Tau propagation and Tau pathology in vivo. Nat Neurosci. 2016;19(8):1085\u201392.","journal-title":"Nat Neurosci"},{"issue":"4","key":"698_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714.","journal-title":"Cell"},{"issue":"8","key":"698_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","volume":"71","author":"S Ooms","year":"2014","unstructured":"Ooms S, et al. Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 2014;71(8):971\u20137.","journal-title":"JAMA Neurol"},{"issue":"8","key":"698_CR9","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"YS Ju","year":"2017","unstructured":"Ju YS, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-\u03b2 levels. Brain. 2017;140(8):2104\u201311.","journal-title":"Brain"},{"issue":"1","key":"698_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ana.25117","volume":"83","author":"BP Lucey","year":"2018","unstructured":"Lucey BP, et al. Effect of sleep on overnight cerebrospinal fluid amyloid \u03b2 kinetics. Ann Neurol. 2018;83(1):197\u2013204.","journal-title":"Ann Neurol"},{"issue":"6429","key":"698_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth JK, et al. The sleep-wake cycle regulates brain interstitial fluid Tau in mice and CSF Tau in humans. Science. 2019;363(6429):880\u20134.","journal-title":"Science"},{"issue":"5","key":"698_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ana.25702","volume":"87","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, et al. Sleep deprivation affects Tau phosphorylation in human cerebrospinal fluid. Ann Neurol. 2020;87(5):700\u20139.","journal-title":"Ann Neurol"},{"issue":"12","key":"698_CR13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jamaneurol.2013.4215","volume":"70","author":"ASP Lim","year":"2013","unstructured":"Lim ASP, et al. Modification of the relationship of the Apolipoprotein E \u03b54 allele to the risk of alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013;70(12):1544\u201351.","journal-title":"JAMA Neurol"},{"issue":"11","key":"698_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jagp.2013.04.015","volume":"22","author":"EA Hahn","year":"2014","unstructured":"Hahn EA, et al. A change in sleep pattern May predict alzheimer disease. Am J Geriatric Psychiatry. 2014;22(11):1262\u201371.","journal-title":"Am J Geriatric Psychiatry"},{"issue":"147","key":"698_CR15","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra111.","journal-title":"Sci Transl Med"},{"issue":"6156","key":"698_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373\u20137.","journal-title":"Science"},{"key":"698_CR17","doi-asserted-by":"crossref","unstructured":"Miao A et al. Brain clearance is reduced during sleep and anesthesia. Nat Neurosci, 2024.","DOI":"10.1038\/s41593-024-01638-y"},{"key":"698_CR18","doi-asserted-by":"crossref","unstructured":"Kroesbergen E, et al. Glymphatic clearance is enhanced during sleep. bioRxiv; 2024.","DOI":"10.1101\/2024.08.24.609514"},{"issue":"3","key":"698_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2024.11.027","volume":"188","author":"NL Hauglund","year":"2025","unstructured":"Hauglund NL, et al. Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep. Cell. 2025;188(3):606\u2013e62217.","journal-title":"Cell"},{"key":"698_CR20","doi-asserted-by":"crossref","unstructured":"Olsson M et al. Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. Sleep, 2018. 41(5).","DOI":"10.1093\/sleep\/zsy025"},{"issue":"8002","key":"698_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-024-07108-6","volume":"627","author":"LF Jiang-Xie","year":"2024","unstructured":"Jiang-Xie LF, et al. Neuronal dynamics direct cerebrospinal fluid perfusion and brain clearance. Nature. 2024;627(8002):157\u201364.","journal-title":"Nature"},{"issue":"8002","key":"698_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-024-07132-6","volume":"627","author":"MH Murdock","year":"2024","unstructured":"Murdock MH, et al. Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature. 2024;627(8002):149\u201356.","journal-title":"Nature"},{"issue":"5955","key":"698_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang JE, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005\u20137.","journal-title":"Science"},{"key":"698_CR24","doi-asserted-by":"crossref","unstructured":"Forsberg M, et al. Ion concentrations in cerebrospinal fluid in wakefulness, sleep and sleep deprivation in healthy humans. J Sleep Res. 2021. p. e13522.","DOI":"10.1111\/jsr.13522"},{"issue":"6","key":"698_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-2600(19)30057-8","volume":"7","author":"MI Boulos","year":"2019","unstructured":"Boulos MI, et al. Normal polysomnography parameters in healthy adults: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(6):533\u201343.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"698_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5664\/jcsm.4758","volume":"11","author":"NF Watson","year":"2015","unstructured":"Watson NF, et al. Recommended amount of sleep for a healthy adult: A joint consensus statement of the American academy of sleep medicine and sleep research society. J Clin Sleep Med. 2015;11(6):591\u20132.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"698_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","volume":"10","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, et al. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. 2018;10(1):8.","journal-title":"Alzheimers Res Ther"},{"issue":"2\u20133","key":"698_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0165-0270(92)90004-W","volume":"44","author":"LE Rosengren","year":"1992","unstructured":"Rosengren LE, et al. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods. 1992;44(2\u20133):113\u20139.","journal-title":"J Neurosci Methods"},{"issue":"3","key":"698_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","volume":"136","author":"E Portelius","year":"2018","unstructured":"Portelius E, et al. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol. 2018;136(3):363\u201376.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"698_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000358800","volume":"14","author":"E Portelius","year":"2014","unstructured":"Portelius E, et al. Exploring alzheimer molecular pathology in down\u2019s syndrome cerebrospinal fluid. Neurodegener Dis. 2014;14(2):98\u2013106.","journal-title":"Neurodegener Dis"},{"issue":"1","key":"698_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1113\/jphysiol.2014.284711","volume":"593","author":"A Bjorefeldt","year":"2015","unstructured":"Bjorefeldt A, et al. Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice. J Physiol. 2015;593(1):231\u201343.","journal-title":"J Physiol"},{"issue":"1","key":"698_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13195-024-01503-x","volume":"16","author":"A Ordu\u00f1a Dolado","year":"2024","unstructured":"Ordu\u00f1a Dolado A, et al. Effects of time of the day at sampling on CSF and plasma levels of alzheimer\u2019 disease biomarkers. Alzheimers Res Ther. 2024;16(1):132.","journal-title":"Alzheimers Res Ther"},{"issue":"1\u20132","key":"698_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0166-4328(95)00017-N","volume":"69","author":"P Maquet","year":"1995","unstructured":"Maquet P. Sleep function(s) and cerebral metabolism. Behav Brain Res. 1995;69(1\u20132):75\u201383.","journal-title":"Behav Brain Res"},{"issue":"4","key":"698_CR34","first-page":"281","volume":"3","author":"PL Madsen","year":"1991","unstructured":"Madsen PL, Vorstrup S. Cerebral blood flow and metabolism during sleep. Cerebrovasc Brain Metab Rev. 1991;3(4):281\u201396.","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"698_CR35","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.smrv.2024.101977","volume":"77","author":"RFM Al-Shama","year":"2024","unstructured":"Al-Shama RFM, et al. Cerebral blood flow in sleep: A systematic review and meta-analysis. Sleep Med Rev. 2024;77:101977.","journal-title":"Sleep Med Rev"},{"key":"698_CR36","unstructured":"Troester MM, et al. The AASM manual for the scoring of sleep and associated events, version 3. American Academy Of Sleep Medicine; 2023."},{"issue":"1\u20132","key":"698_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2003.12.002","volume":"219","author":"S Seyfert","year":"2004","unstructured":"Seyfert S, Faulstich A, Marx P. What determines the CSF concentrations of albumin and plasma-derived IgG? J Neurol Sci. 2004;219(1\u20132):31\u20133.","journal-title":"J Neurol Sci"},{"issue":"1","key":"698_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, et al. Endothelial LRP1 transports amyloid-\u03b2(1\u201342) across the blood-brain barrier. J Clin Invest. 2016;126(1):123\u201336.","journal-title":"J Clin Invest"},{"issue":"46","key":"698_CR39","doi-asserted-by":"publisher","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","volume":"32","author":"T Kanekiyo","year":"2012","unstructured":"Kanekiyo T, et al. LRP1 in brain vascular smooth muscle cells mediates local clearance of alzheimer\u2019s amyloid-\u03b2. J Neurosci. 2012;32(46):16458\u201365.","journal-title":"J Neurosci"},{"issue":"7803","key":"698_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, et al. LRP1 is a master regulator of Tau uptake and spread. Nature. 2020;580(7803):381\u20135.","journal-title":"Nature"},{"key":"698_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2015.01.067","volume":"590","author":"R Mehta","year":"2015","unstructured":"Mehta R, Khanday MA, Mallick BN. REM sleep loss associated changes in orexin-A levels in discrete brain areas in rats. Neurosci Lett. 2015;590:62\u20137.","journal-title":"Neurosci Lett"},{"issue":"3","key":"698_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuroscience.2004.07.049","volume":"129","author":"T Deboer","year":"2004","unstructured":"Deboer T, et al. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience. 2004;129(3):727\u201332.","journal-title":"Neuroscience"},{"issue":"2","key":"698_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","volume":"54","author":"RM Salomon","year":"2003","unstructured":"Salomon RM, et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry. 2003;54(2):96\u2013104.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"698_CR44","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1523\/JNEUROSCI.23-08-03555.2003","volume":"23","author":"JM Zeitzer","year":"2003","unstructured":"Zeitzer JM, et al. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci. 2003;23(8):3555\u201360.","journal-title":"J Neurosci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00698-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:45:29Z","timestamp":1781606729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00698-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00698-x","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Swedish Ethical Review Authority in Gothenburg (Regionala etikpr\u00f6vningsn\u00e4mnden i G\u00f6teborg), protocol number #492\u2009\u2212\u200918. Each participant gave oral and written informed consent to participate in the study before inclusion. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for AbbVie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave; has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche; and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}